Bridge Pharmaceuticals Boosts China's Biotech Industry
Filed in archive Incubators and Science Parks by james on December 06, 2005
Bridge Pharmaceuticals, spun off only a year ago by SRI International in Stanford University, and backed by an initial $3.5 million financing from WI Harper, is primarily focused on cost-effective development of FDA-compliant therapeutic drugs in Asia for the U.S. and E.U. markets.
Other investors include the YFY Group, Taiwan's Industrial Technology Research Institute; and the Development Center for Biotechnology, a Taiwan-based not-for-profit organization. SRI holds an 18 percent stake in Bridge.
Just a week ago, a delegation of some of San Francisco's prominent politicians, including the charismatic young Mayor Gavin Newsom, traveled to Beijing, along with Mr. Liu, to dedicate the company's recently completed Bridge Zhongguancun Preclinical Drug Development Laboratory. According to Red Herring, The Vital Bridge Zhongguancun Drug Development Laboratory is a joint venture between Bridge Pharmaceuticals, the Menlo Park, California-based contract research organization (CRO), and Vital Star, a subsidiary of the Beijing Laboratory Animal Research Center (BLARC).
Bridge holds a 65 percent stake in the lab, while Vital Star holds a 35 percent stake. Located in the Zhongguancun Life Sciences Park in the northern Beijing suburb of Changping, the facility will conduct animal testing
for pharmaceutical industry clients.With America's direct assistance in the form of technology development and fueled by venture funds, China is well on its way to realizing its Biotech development plans which include establishing 20 world-level research and development centers and 10 biotech centers with an annual output value in excess of $30 billion according to sources at the China Bio-engineering Development Center under the Ministry of Science and Technology.
There are some folks in Washington still wondering why Silicon Valley and Stanford University is helping China's develop these pillar industries? It was not that long ago that the US was playing catch up with Japan in biotechnology deals and development.
Permalink: Bridge Pharmaceuticals Boosts China's Biotech Industry
Tags:
China biotech china venture bridge bridge+pharmaceuticals china+biotech biotech+industry
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/11957













